HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A clinical analysis of cutaneous type dermatomyositis].

Abstract
This paper reports nine patients with the classic cutaneous findings of dermatomyositis who did not develop clinical or laboratory evidence of muscle disease for at least 2 years after onset of their skin manifestations. Such patients represent 3.5% of our total experience with dermatomyositis patients during a 12 years period. None of the patients had evidence of malignancy. Each of five patients treated with oral prednisone for their cutaneous lesion or mild myositis after onset of their skin manifestations 3-12 years and had marked improvement. The author emphasizes that the cutaneous manifestations of dermatomyositis are pathognomonic of this disease and the term of this disease proposes cutaneous type dermatomyositis better than amyopathic dermatomyositis.
AuthorsB Yu
JournalZhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae (Zhongguo Yi Xue Ke Xue Yuan Xue Bao) Vol. 16 Issue 5 Pg. 394-6 (Oct 1994) ISSN: 1000-503X [Print] China
PMID7720134 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Ointments
  • Silicone Oils
  • Prednisone
  • Ibuprofen
Topics
  • Adult
  • Child
  • Child, Preschool
  • Dermatomyositis (drug therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Ibuprofen (therapeutic use)
  • Male
  • Middle Aged
  • Ointments
  • Prednisone (therapeutic use)
  • Silicone Oils (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: